Clinically Differentiated Glucokinase Activator HMS5552: Effective Control of 24-Hour Glucose and Improvement of β Cell Function in T2DM Patients-Poster and Presentation-Hua Medicine

CQ9电子·(China)中国区官方网站CQ9电子

Our Science

Clinically Differentiated Glucokinase Activator HMS5552: Effective Control of 24-Hour Glucose and Improvement of β Cell Function in T2DM Patients

2015 ADA Poster
Hua Medicine
Jun 05, 2015
5281

Online link unavailable, presentation available upon request. (BD@thanosbox.com)

Focus Us
Copyright © 2025  Hua Medicine (Shanghai) Co., Ltd.    互联网药品信息服务资格证书编号: （沪）-非经营-2022-0079
沪ICP备88185979号-1  beiantubiao.png 沪公网安备 31011502013809号  Privacy Statement  Terms of Use
Search
How we use cookies
Hua Medicine uses cookies to enable and improve the use of the website. By continuing to use the site, you consent to the use of these cookies. To learn more about cookies, please read our privacy statement.
Accept
x
网站首页
CQ9电子